Effectiveness of adalimumab in severe ulcerative colitis: A systematic review and a meta‐analysis
Abstract Background and Aim Ulcerative colitis (UC) causes chronic inflammation in the digestive tract, leading to abdominal pain and diarrhea. Adalimumab, a monoclonal antibody, is used to treat moderate to severe cases. This review and meta‐analysis evaluated adalimumab's effectiveness for se...
| Príomhchruthaitheoirí: | , , , |
|---|---|
| Formáid: | Alt |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
Wiley
2024-07-01
|
| Sraith: | Health Science Reports |
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.1002/hsr2.2210 |